{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T15:16:10Z","timestamp":1791213370095,"version":"4.1.0"},"reference-count":157,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,4,30]],"date-time":"2024-04-30T00:00:00Z","timestamp":1714435200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,4,30]],"date-time":"2024-04-30T00:00:00Z","timestamp":1714435200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01GM135921"],"award-info":[{"award-number":["R01GM135921"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000001","name":"National Science Foundation","doi-asserted-by":"publisher","award":["CBET-1932192"],"award-info":[{"award-number":["CBET-1932192"]}],"id":[{"id":"10.13039\/100000001","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000001","name":"National Science Foundation","doi-asserted-by":"publisher","award":["CBET-2319956"],"award-info":[{"award-number":["CBET-2319956"]}],"id":[{"id":"10.13039\/100000001","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Korean Fund for Regenerative Medicine","award":["21A0504L"],"award-info":[{"award-number":["21A0504L"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nano Convergence"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Ischemia-reperfusion injury (IRI) poses significant challenges across various organ systems, including the heart, brain, and kidneys. Exosomes have shown great potentials and applications in mitigating IRI-induced cell and tissue damage through modulating inflammatory responses, enhancing angiogenesis, and promoting tissue repair. Despite these advances, a more systematic understanding of exosomes from different sources and their biotransport is critical for optimizing therapeutic efficacy and accelerating the clinical adoption of exosomes for IRI therapies. Therefore, this review article overviews the administration routes of exosomes from different sources, such as mesenchymal stem cells and other somatic cells, in the context of IRI treatment. Furthermore, this article covers how the delivered exosomes modulate molecular pathways of recipient cells, aiding in the prevention of cell death and the promotions of regeneration in IRI models. In the end, this article discusses the ongoing research efforts and propose future research directions of exosome-based therapies.<\/jats:p>\n                <jats:p><jats:bold>Graphical Abstract<\/jats:bold><\/jats:p>","DOI":"10.1186\/s40580-024-00423-8","type":"journal-article","created":{"date-parts":[[2024,4,30]],"date-time":"2024-04-30T17:02:11Z","timestamp":1714496531000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":29,"title":["Delivery-mediated exosomal therapeutics in ischemia\u2013reperfusion injury: advances, mechanisms, and future directions"],"prefix":"10.1186","volume":"11","author":[{"given":"Shengzhe","family":"Ding","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-Jin","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kai-Yu","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Um","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Youngmee","family":"Jung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4966-4396","authenticated-orcid":false,"given":"Hyunjoon","family":"Kong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,4,30]]},"reference":[{"key":"423_CR1","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1016\/B978-0-12-394309-5.00006-7","volume":"298","author":"T Kalogeris","year":"2012","unstructured":"T. Kalogeris, C.P. Baines, M. Krenz, R.J. Korthuis, Cell biology of ischemia\/reperfusion injury. Int Rev Cell Mol Biol 298, 229\u2013317 (2012). https:\/\/doi.org\/10.1016\/B978-0-12-394309-5.00006-7","journal-title":"Int Rev Cell Mol Biol"},{"key":"423_CR2","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.ebiom.2018.01.025","volume":"28","author":"H Zhao","year":"2018","unstructured":"H. Zhao, A. Alam, A.P. Soo, A.J.T. George, D. Ma, Ischemia-reperfusion injury reduces long term renal graft survival: mechanism and beyond. EBioMedicine 28, 31\u201342 (2018). https:\/\/doi.org\/10.1016\/j.ebiom.2018.01.025","journal-title":"EBioMedicine"},{"key":"423_CR3","doi-asserted-by":"publisher","DOI":"10.3390\/ijms20205034","author":"ROS Soares","year":"2019","unstructured":"R.O.S. Soares, D.M. Losada, M.C. Jordani, P. Evora, E.S.O. Castro, Ischemia\/reperfusion injury revisited: an overview of the latest pharmacological strategies. Int J Mol Sci (2019). https:\/\/doi.org\/10.3390\/ijms20205034","journal-title":"Int J Mol Sci"},{"key":"423_CR4","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1186\/1749-8090-8-17","volume":"8","author":"J Xiong","year":"2013","unstructured":"J. Xiong et al., Early malperfusion, ischemia reperfusion injury, and respiratory failure in acute complicated type B aortic dissection after thoracic endovascular repair. J Cardiothorac Surg 8, 17 (2013). https:\/\/doi.org\/10.1186\/1749-8090-8-17","journal-title":"J Cardiothorac Surg"},{"key":"423_CR5","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.1056\/NEJMra071667","volume":"357","author":"DM Yellon","year":"2007","unstructured":"D.M. Yellon, D.J. Hausenloy, Myocardial reperfusion injury. N Engl J Med 357, 1121\u20131135 (2007). https:\/\/doi.org\/10.1056\/NEJMra071667","journal-title":"N Engl J Med"},{"key":"423_CR6","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1186\/s13054-019-2667-3","volume":"23","author":"H Chen","year":"2019","unstructured":"H. Chen, F. Wu, P. Yang, J. Shao, Q. Chen, R. Zheng, A meta-analysis of the effects of therapeutic hypothermia in adult patients with traumatic brain injury. Crit Care 23, 396 (2019). https:\/\/doi.org\/10.1186\/s13054-019-2667-3","journal-title":"Crit Care"},{"key":"423_CR7","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.nurt.2009.10.015","volume":"7","author":"WD Dietrich","year":"2010","unstructured":"W.D. Dietrich, H.M. Bramlett, The evidence for hypothermia as a neuroprotectant in traumatic brain injury. Neurotherapeutics 7, 43\u201350 (2010). https:\/\/doi.org\/10.1016\/j.nurt.2009.10.015","journal-title":"Neurotherapeutics"},{"key":"423_CR8","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1089\/ther.2011.0012","volume":"1","author":"S Yokobori","year":"2011","unstructured":"S. Yokobori et al., The use of hypothermia therapy in traumatic ischemic\/reperfusional brain injury: review of the literatures. Ther Hypothermia Temp Manag 1, 185\u2013192 (2011). https:\/\/doi.org\/10.1089\/ther.2011.0012","journal-title":"Ther Hypothermia Temp Manag"},{"key":"423_CR9","doi-asserted-by":"publisher","first-page":"355","DOI":"10.2174\/0929867324666170608111917","volume":"25","author":"M Bartekova","year":"2018","unstructured":"M. Bartekova, M. Barancik, K. Ferenczyova, N.S. Dhalla, Beneficial effects of N-acetylcysteine and N-mercaptopropionylglycine on ischemia reperfusion injury in the heart. Curr Med Chem 25, 355\u2013366 (2018). https:\/\/doi.org\/10.2174\/0929867324666170608111917","journal-title":"Curr Med Chem"},{"key":"423_CR10","doi-asserted-by":"publisher","first-page":"808","DOI":"10.1080\/08941939.2020.1714823","volume":"34","author":"JM Softeland","year":"2021","unstructured":"J.M. Softeland, M. Oltean, Intestinal ischemia-reperfusion injury and calcium channel blockers: getting to the core of the problem. J Invest Surg 34, 808\u2013809 (2021). https:\/\/doi.org\/10.1080\/08941939.2020.1714823","journal-title":"J Invest Surg"},{"key":"423_CR11","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1186\/s12951-022-01474-x","volume":"20","author":"D Liu","year":"2022","unstructured":"D. Liu et al., Cyclosporine a loaded brain targeting nanoparticle to treat cerebral ischemia\/reperfusion injury in mice. J Nanobiotechnol 20, 256 (2022). https:\/\/doi.org\/10.1186\/s12951-022-01474-x","journal-title":"J Nanobiotechnol"},{"key":"423_CR12","doi-asserted-by":"publisher","first-page":"2659","DOI":"10.1161\/01.STR.0000144051.32131.09","volume":"35","author":"S Warach","year":"2004","unstructured":"S. Warach, L.L. Latour, Evidence of reperfusion injury, exacerbated by thrombolytic therapy, in human focal brain ischemia using a novel imaging marker of early blood-brain barrier disruption. Stroke 35, 2659\u20132661 (2004). https:\/\/doi.org\/10.1161\/01.STR.0000144051.32131.09","journal-title":"Stroke"},{"key":"423_CR13","unstructured":"K. Mandalaneni, A. Rayi, D.V. Jillella, Stroke Reperfusion Injury, In: StatPearls [Internet], StatPearls Publishing: Treasure Island (FL),  2024 Jan, https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK564350"},{"key":"423_CR14","doi-asserted-by":"publisher","first-page":"101398","DOI":"10.1016\/j.cpcardiol.2022.101398","volume":"47","author":"A Schafer","year":"2022","unstructured":"A. Schafer, T. Konig, J. Bauersachs, M. Akin, Novel therapeutic strategies to reduce reperfusion injury after acute myocardial infarction. Curr Probl Cardiol 47, 101398 (2022). https:\/\/doi.org\/10.1016\/j.cpcardiol.2022.101398","journal-title":"Curr Probl Cardiol"},{"key":"423_CR15","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1016\/j.tcm.2022.02.005","volume":"33","author":"M Algoet","year":"2023","unstructured":"M. Algoet et al., Myocardial ischemia-reperfusion injury and the influence of inflammation. Trend Cardiovasc Med 33, 357\u2013366 (2023). https:\/\/doi.org\/10.1016\/j.tcm.2022.02.005","journal-title":"Trend Cardiovasc Med"},{"key":"423_CR16","doi-asserted-by":"publisher","first-page":"20","DOI":"10.12861\/jrip.2015.06","volume":"4","author":"M Malek","year":"2015","unstructured":"M. Malek, M. Nematbakhsh, Renal ischemia\/reperfusion injury from pathophysiology to treatment. J Renal Inj Prev 4, 20\u201327 (2015). https:\/\/doi.org\/10.12861\/jrip.2015.06","journal-title":"J Renal Inj Prev"},{"key":"423_CR17","doi-asserted-by":"publisher","DOI":"10.3390\/ijms20071619","author":"CW Yun","year":"2019","unstructured":"C.W. Yun, S.H. Lee, Potential and therapeutic efficacy of cell-based therapy using mesenchymal stem cells for acute\/chronic kidney disease. Int J Mol Sci (2019). https:\/\/doi.org\/10.3390\/ijms20071619","journal-title":"Int J Mol Sci"},{"key":"423_CR18","doi-asserted-by":"publisher","DOI":"10.1126\/science.aau6977","author":"R Kalluri","year":"2020","unstructured":"R. Kalluri, V.S. LeBleu, The biology, function, and biomedical applications of exosomes. Science (2020). https:\/\/doi.org\/10.1126\/science.aau6977","journal-title":"Science"},{"key":"423_CR19","doi-asserted-by":"publisher","DOI":"10.3390\/cells8070727","author":"LM Doyle","year":"2019","unstructured":"L.M. Doyle, M.Z. Wang, Overview of extracellular vesicles, their origin, composition, purpose, and methods for exosome isolation and analysis. Cells (2019). https:\/\/doi.org\/10.3390\/cells8070727","journal-title":"Cells"},{"key":"423_CR20","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1038\/cr.2017.71","volume":"27","author":"Z Zhao","year":"2017","unstructured":"Z. Zhao, B.V. Zlokovic, Remote control of BBB: a tale of exosomes and microRNA. Cell Res 27, 849\u2013850 (2017). https:\/\/doi.org\/10.1038\/cr.2017.71","journal-title":"Cell Res"},{"key":"423_CR21","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/s12929-019-0502-4","volume":"26","author":"CY Chiang","year":"2019","unstructured":"C.Y. Chiang, C. Chen, Toward characterizing extracellular vesicles at a single-particle level. J Biomed Sci 26, 9 (2019). https:\/\/doi.org\/10.1186\/s12929-019-0502-4","journal-title":"J Biomed Sci"},{"key":"423_CR22","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.jconrel.2015.03.033","volume":"207","author":"MJ Haney","year":"2015","unstructured":"M.J. Haney et al., Exosomes as drug delivery vehicles for parkinson\u2019s disease therapy. J Control Releas 207, 18\u201330 (2015). https:\/\/doi.org\/10.1016\/j.jconrel.2015.03.033","journal-title":"J Control Releas"},{"key":"423_CR23","doi-asserted-by":"publisher","DOI":"10.3390\/cancers15071992","author":"NCH Lau","year":"2023","unstructured":"N.C.H. Lau, J.W.P. Yam, From exosome biogenesis to absorption: key takeaways for cancer research. Cancers (2023). https:\/\/doi.org\/10.3390\/cancers15071992","journal-title":"Cancers"},{"key":"423_CR24","doi-asserted-by":"publisher","DOI":"10.1007\/s12035-024-04026-6","author":"J Zhang","year":"2024","unstructured":"J. Zhang et al., M2 microglia-derived exosomes promote spinal cord injury recovery in mice by alleviating A1 astrocyte activation. Mol Neurobiol (2024). https:\/\/doi.org\/10.1007\/s12035-024-04026-6","journal-title":"Mol Neurobiol"},{"key":"423_CR25","doi-asserted-by":"publisher","first-page":"105173","DOI":"10.1016\/j.neuint.2021.105173","volume":"150","author":"LD Moss","year":"2021","unstructured":"L.D. Moss et al., Intranasal delivery of exosomes from human adipose derived stem cells at forty-eight hours post injury reduces motor and cognitive impairments following traumatic brain injury. Neurochem Int 150, 105173 (2021). https:\/\/doi.org\/10.1016\/j.neuint.2021.105173","journal-title":"Neurochem Int"},{"key":"423_CR26","doi-asserted-by":"publisher","first-page":"011503","DOI":"10.1063\/1.5087122","volume":"3","author":"X Li","year":"2019","unstructured":"X. Li et al., Challenges and opportunities in exosome research-Perspectives from biology, engineering, and cancer therapy. APL Bioeng 3, 011503 (2019). https:\/\/doi.org\/10.1063\/1.5087122","journal-title":"APL Bioeng"},{"key":"423_CR27","doi-asserted-by":"publisher","first-page":"751079","DOI":"10.3389\/fcell.2021.751079","volume":"9","author":"H Chen","year":"2021","unstructured":"H. Chen et al., Exosomes, a new star for targeted delivery. Front Cell Dev Biol 9, 751079 (2021). https:\/\/doi.org\/10.3389\/fcell.2021.751079","journal-title":"Front Cell Dev Biol"},{"key":"423_CR28","doi-asserted-by":"publisher","first-page":"1391","DOI":"10.1038\/nm.2507","volume":"17","author":"HK Eltzschig","year":"2011","unstructured":"H.K. Eltzschig, T. Eckle, Ischemia and reperfusion\u2013from mechanism to translation. Nat Med 17, 1391\u20131401 (2011). https:\/\/doi.org\/10.1038\/nm.2507","journal-title":"Nat Med"},{"key":"423_CR29","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1038\/s41569-020-0403-y","volume":"17","author":"G Heusch","year":"2020","unstructured":"G. Heusch, Myocardial ischaemia-reperfusion injury and cardioprotection in perspective. Nat Rev Cardiol 17, 773\u2013789 (2020). https:\/\/doi.org\/10.1038\/s41569-020-0403-y","journal-title":"Nat Rev Cardiol"},{"key":"423_CR30","doi-asserted-by":"publisher","first-page":"109945","DOI":"10.1016\/j.biopha.2020.109945","volume":"125","author":"Y Wang","year":"2020","unstructured":"Y. Wang et al., Protection against acute cerebral ischemia\/reperfusion injury by QiShenYiQi via neuroinflammatory network mobilization. Biomed Pharmacother 125, 109945 (2020). https:\/\/doi.org\/10.1016\/j.biopha.2020.109945","journal-title":"Biomed Pharmacother"},{"key":"423_CR31","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1186\/s12891-020-03607-5","volume":"21","author":"Y Li","year":"2020","unstructured":"Y. Li et al., Correction to: Bilobalide protects against ischemia\/reperfusion-induced oxidative stress and inflammatory responses via the MAPK\/NF-kappaB pathways in rats. BMC Musculoskelet Disord 21, 584 (2020). https:\/\/doi.org\/10.1186\/s12891-020-03607-5","journal-title":"BMC Musculoskelet Disord"},{"key":"423_CR32","doi-asserted-by":"publisher","first-page":"101836","DOI":"10.1016\/j.redox.2020.101836","volume":"39","author":"G Zhang","year":"2021","unstructured":"G. Zhang et al., Renovascular effects of inorganic nitrate following ischemia-reperfusion of the kidney. Redox Biol 39, 101836 (2021). https:\/\/doi.org\/10.1016\/j.redox.2020.101836","journal-title":"Redox Biol"},{"key":"423_CR33","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1016\/j.cmet.2015.12.009","volume":"23","author":"ET Chouchani","year":"2016","unstructured":"E.T. Chouchani et al., A unifying mechanism for mitochondrial superoxide production during ischemia-reperfusion injury. Cell Metab 23, 254\u2013263 (2016). https:\/\/doi.org\/10.1016\/j.cmet.2015.12.009","journal-title":"Cell Metab"},{"key":"423_CR34","doi-asserted-by":"publisher","first-page":"2332","DOI":"10.1161\/01.cir.0000016602.96363.36","volume":"105","author":"S Verma","year":"2002","unstructured":"S. Verma et al., Fundamentals of reperfusion injury for the clinical cardiologist. Circulation 105, 2332\u20132336 (2002). https:\/\/doi.org\/10.1161\/01.cir.0000016602.96363.36","journal-title":"Circulation"},{"key":"423_CR35","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1056\/NEJMoa071142","volume":"359","author":"C Piot","year":"2008","unstructured":"C. Piot et al., Effect of cyclosporine on reperfusion injury in acute myocardial infarction. N Engl J Med 359, 473\u2013481 (2008). https:\/\/doi.org\/10.1056\/NEJMoa071142","journal-title":"N Engl J Med"},{"key":"423_CR36","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1172\/JCI62874","volume":"123","author":"DJ Hausenloy","year":"2013","unstructured":"D.J. Hausenloy, D.M. Yellon, Myocardial ischemia-reperfusion injury: a neglected therapeutic target. J Clin Invest 123, 92\u2013100 (2013). https:\/\/doi.org\/10.1172\/JCI62874","journal-title":"J Clin Invest"},{"key":"423_CR37","doi-asserted-by":"publisher","first-page":"1349","DOI":"10.1177\/0271678X221089074","volume":"42","author":"XM Zha","year":"2022","unstructured":"X.M. Zha, Z.G. Xiong, R.P. Simon, pH and proton-sensitive receptors in brain ischemia. J Cereb Blood Flow Metab 42, 1349\u20131363 (2022). https:\/\/doi.org\/10.1177\/0271678X221089074","journal-title":"J Cereb Blood Flow Metab"},{"key":"423_CR38","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1146\/annurev-pharmtox-010715-103335","volume":"57","author":"EJ Lesnefsky","year":"2017","unstructured":"E.J. Lesnefsky, Q. Chen, B. Tandler, C.L. Hoppel, Mitochondrial dysfunction and myocardial ischemia-reperfusion: implications for novel therapies. Annu Rev Pharmacol Toxicol 57, 535\u2013565 (2017). https:\/\/doi.org\/10.1146\/annurev-pharmtox-010715-103335","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"423_CR39","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1161\/STROKEAHA.107.496588","volume":"39","author":"B Boden-Albala","year":"2008","unstructured":"B. Boden-Albala et al., Metabolic syndrome and ischemic stroke risk: northern manhattan study. Stroke 39, 30\u201335 (2008). https:\/\/doi.org\/10.1161\/STROKEAHA.107.496588","journal-title":"Stroke"},{"key":"423_CR40","doi-asserted-by":"publisher","first-page":"F551","DOI":"10.1152\/ajprenal.00492.2016","volume":"312","author":"JD Pressly","year":"2017","unstructured":"J.D. Pressly, F. Park, DNA repair in ischemic acute kidney injury. Am J Physiol Renal Physiol 312, F551\u2013F555 (2017). https:\/\/doi.org\/10.1152\/ajprenal.00492.2016","journal-title":"Am J Physiol Renal Physiol"},{"key":"423_CR41","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1161\/CIRCRESAHA.110.232173","volume":"108","author":"MJ Kohr","year":"2011","unstructured":"M.J. Kohr et al., Simultaneous measurement of protein oxidation and S-nitrosylation during preconditioning and ischemia\/reperfusion injury with resin-assisted capture. Circ Res 108, 418\u2013426 (2011). https:\/\/doi.org\/10.1161\/CIRCRESAHA.110.232173","journal-title":"Circ Res"},{"key":"423_CR42","doi-asserted-by":"publisher","first-page":"2003","DOI":"10.3969\/j.issn.1673-5374.2013.21.009","volume":"8","author":"C Guo","year":"2013","unstructured":"C. Guo, L. Sun, X. Chen, D. Zhang, Oxidative stress, mitochondrial damage and neurodegenerative diseases. Neural Regen Res 8, 2003\u20132014 (2013). https:\/\/doi.org\/10.3969\/j.issn.1673-5374.2013.21.009","journal-title":"Neural Regen Res"},{"key":"423_CR43","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1161\/01.res.88.5.529","volume":"88","author":"T Ide","year":"2001","unstructured":"T. Ide et al., Mitochondrial DNA damage and dysfunction associated with oxidative stress in failing hearts after myocardial infarction. Circ Res 88, 529\u2013535 (2001). https:\/\/doi.org\/10.1161\/01.res.88.5.529","journal-title":"Circ Res"},{"key":"423_CR44","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1016\/bs.ircmb.2018.05.006","volume":"340","author":"C Giorgi","year":"2018","unstructured":"C. Giorgi et al., Mitochondria and reactive oxygen species in aging and age-related diseases. Int Rev Cell Mol Biol 340, 209\u2013344 (2018). https:\/\/doi.org\/10.1016\/bs.ircmb.2018.05.006","journal-title":"Int Rev Cell Mol Biol"},{"key":"423_CR45","doi-asserted-by":"publisher","first-page":"1471","DOI":"10.1016\/j.healun.2015.05.007","volume":"34","author":"AJ Dare","year":"2015","unstructured":"A.J. Dare et al., The mitochondria-targeted anti-oxidant MitoQ decreases ischemia-reperfusion injury in a murine syngeneic heart transplant model. J Heart Lung Transplant 34, 1471\u20131480 (2015). https:\/\/doi.org\/10.1016\/j.healun.2015.05.007","journal-title":"J Heart Lung Transplant"},{"key":"423_CR46","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1038\/s41577-022-00760-x","volume":"23","author":"S Marchi","year":"2023","unstructured":"S. Marchi, E. Guilbaud, S.W.G. Tait, T. Yamazaki, L. Galluzzi, Mitochondrial control of inflammation. Nat Rev Immunol 23, 159\u2013173 (2023). https:\/\/doi.org\/10.1038\/s41577-022-00760-x","journal-title":"Nat Rev Immunol"},{"key":"423_CR47","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.jconrel.2011.03.022","volume":"153","author":"VV Shuvaev","year":"2011","unstructured":"V.V. Shuvaev, V.R. Muzykantov, Targeted modulation of reactive oxygen species in the vascular endothelium. J Control Releas 153, 56\u201363 (2011). https:\/\/doi.org\/10.1016\/j.jconrel.2011.03.022","journal-title":"J Control Releas"},{"key":"423_CR48","doi-asserted-by":"publisher","first-page":"826","DOI":"10.1038\/nri2873","volume":"10","author":"GY Chen","year":"2010","unstructured":"G.Y. Chen, G. Nunez, Sterile inflammation: sensing and reacting to damage. Nat Rev Immunol 10, 826\u2013837 (2010). https:\/\/doi.org\/10.1038\/nri2873","journal-title":"Nat Rev Immunol"},{"key":"423_CR49","doi-asserted-by":"publisher","first-page":"1526","DOI":"10.1038\/ki.2008.500","volume":"74","author":"L Li","year":"2008","unstructured":"L. Li et al., The chemokine receptors CCR2 and CX3CR1 mediate monocyte\/macrophage trafficking in kidney ischemia-reperfusion injury. Kidney Int 74, 1526\u20131537 (2008). https:\/\/doi.org\/10.1038\/ki.2008.500","journal-title":"Kidney Int"},{"key":"423_CR50","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/j.cca.2022.04.003","volume":"531","author":"C Lei","year":"2022","unstructured":"C. Lei, Y. Tan, D. Ni, J. Peng, G. Yi, cGAS-STING signaling in ischemic diseases. Clin Chim Acta 531, 177\u2013182 (2022). https:\/\/doi.org\/10.1016\/j.cca.2022.04.003","journal-title":"Clin Chim Acta"},{"key":"423_CR51","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1111\/nyas.12885","volume":"1350","author":"G Bhosale","year":"2015","unstructured":"G. Bhosale, J.A. Sharpe, S.Y. Sundier, M.R. Duchen, Calcium signaling as a mediator of cell energy demand and a trigger to cell death. Ann N Y Acad Sci 1350, 107\u2013116 (2015). https:\/\/doi.org\/10.1111\/nyas.12885","journal-title":"Ann N Y Acad Sci"},{"key":"423_CR52","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1016\/s0735-1097(98)00559-2","volume":"33","author":"A Takaoka","year":"1999","unstructured":"A. Takaoka et al., Renal ischemia\/reperfusion remotely improves myocardial energy metabolism during myocardial ischemia via adenosine receptors in rabbits: effects of \u201cremote preconditioning.\u201d J Am Coll Cardiol 33, 556\u2013564 (1999). https:\/\/doi.org\/10.1016\/s0735-1097(98)00559-2","journal-title":"J Am Coll Cardiol"},{"key":"423_CR53","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/s0167-5273(02)00189-4","volume":"86","author":"KA Kaminski","year":"2002","unstructured":"K.A. Kaminski, T.A. Bonda, J. Korecki, W.J. Musial, Oxidative stress and neutrophil activation\u2013the two keystones of ischemia\/reperfusion injury. Int J Cardiol 86, 41\u201359 (2002). https:\/\/doi.org\/10.1016\/s0167-5273(02)00189-4","journal-title":"Int J Cardiol"},{"key":"423_CR54","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1016\/j.pharmthera.2011.11.004","volume":"133","author":"K Raedschelders","year":"2012","unstructured":"K. Raedschelders, D.M. Ansley, D.D. Chen, The cellular and molecular origin of reactive oxygen species generation during myocardial ischemia and reperfusion. Pharmacol Ther 133, 230\u2013255 (2012). https:\/\/doi.org\/10.1016\/j.pharmthera.2011.11.004","journal-title":"Pharmacol Ther"},{"key":"423_CR55","doi-asserted-by":"publisher","first-page":"1382","DOI":"10.1016\/j.bbamcr.2010.12.008","volume":"1813","author":"G Loor","year":"2011","unstructured":"G. Loor et al., Mitochondrial oxidant stress triggers cell death in simulated ischemia-reperfusion. Biochim Biophys Acta 1813, 1382\u20131394 (2011). https:\/\/doi.org\/10.1016\/j.bbamcr.2010.12.008","journal-title":"Biochim Biophys Acta"},{"key":"423_CR56","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1038\/nrcardio.2011.38","volume":"8","author":"F Arslan","year":"2011","unstructured":"F. Arslan, D.P. de Kleijn, G. Pasterkamp, Innate immune signaling in cardiac ischemia. Nat Rev Cardiol 8, 292\u2013300 (2011)","journal-title":"Nat Rev Cardiol"},{"key":"423_CR57","doi-asserted-by":"publisher","first-page":"4892","DOI":"10.1038\/s41467-022-32634-0","volume":"13","author":"L Xu","year":"2022","unstructured":"L. Xu, J. Guo, D.G. Moledina, L.G. Cantley, Immune-mediated tubule atrophy promotes acute kidney injury to chronic kidney disease transition. Nat Commun 13, 4892 (2022). https:\/\/doi.org\/10.1038\/s41467-022-32634-0","journal-title":"Nat Commun"},{"key":"423_CR58","doi-asserted-by":"publisher","first-page":"F887","DOI":"10.1152\/ajprenal.2001.281.5.F887","volume":"281","author":"DP Basile","year":"2001","unstructured":"D.P. Basile, D. Donohoe, K. Roethe, J.L. Osborn, Renal ischemic injury results in permanent damage to peritubular capillaries and influences long-term function. Am J Physiol Renal Physiol 281, F887-899 (2001). https:\/\/doi.org\/10.1152\/ajprenal.2001.281.5.F887","journal-title":"Am J Physiol Renal Physiol"},{"key":"423_CR59","doi-asserted-by":"publisher","DOI":"10.3390\/toxins13050361","author":"K Taguchi","year":"2021","unstructured":"K. Taguchi, K. Fukami, B.C. Elias, C.R. Brooks, Dysbiosis-related advanced glycation endproducts and trimethylamine n-oxide in chronic kidney disease. Toxins (2021). https:\/\/doi.org\/10.3390\/toxins13050361","journal-title":"Toxins"},{"key":"423_CR60","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1111\/j.1749-6632.1997.tb48457.x","volume":"826","author":"L Buee","year":"1997","unstructured":"L. Buee, P.R. Hof, A. Delacourte, Brain microvascular changes in alzheimer\u2019s disease and other dementias. Ann N Y Acad Sci 826, 7\u201324 (1997)","journal-title":"Ann N Y Acad Sci"},{"key":"423_CR61","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1080\/10253890.2016.1174848","volume":"19","author":"M Chomova","year":"2016","unstructured":"M. Chomova, I. Zitnanova, Look into brain energy crisis and membrane pathophysiology in ischemia and reperfusion. Stress 19, 341\u2013348 (2016). https:\/\/doi.org\/10.1080\/10253890.2016.1174848","journal-title":"Stress"},{"key":"423_CR62","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1161\/01.str.26.2.298","volume":"26","author":"J Zhang","year":"1995","unstructured":"J. Zhang, H. Benveniste, B. Klitzman, C.A. Piantadosi, Nitric oxide synthase inhibition and extracellular glutamate concentration after cerebral ischemia\/reperfusion. Stroke 26, 298\u2013304 (1995). https:\/\/doi.org\/10.1161\/01.str.26.2.298","journal-title":"Stroke"},{"key":"423_CR63","doi-asserted-by":"publisher","first-page":"F1433","DOI":"10.1152\/ajprenal.00481.2007","volume":"294","author":"CC Yang","year":"2008","unstructured":"C.C. Yang, C.T. Chien, M.H. Wu, M.C. Ma, C.F. Chen, NMDA receptor blocker ameliorates ischemia-reperfusion-induced renal dysfunction in rat kidneys. Am J Physiol Renal Physiol 294, F1433-1440 (2008). https:\/\/doi.org\/10.1152\/ajprenal.00481.2007","journal-title":"Am J Physiol Renal Physiol"},{"key":"423_CR64","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1097\/00004647-199803000-00008","volume":"18","author":"E Gilland","year":"1998","unstructured":"E. Gilland, M. Puka-Sundvall, L. Hillered, H. Hagberg, Mitochondrial function and energy metabolism after hypoxia-ischemia in the immature rat brain: involvement of NMDA-receptors. J Cereb Blood Flow Metab 18, 297\u2013304 (1998). https:\/\/doi.org\/10.1097\/00004647-199803000-00008","journal-title":"J Cereb Blood Flow Metab"},{"key":"423_CR65","doi-asserted-by":"publisher","first-page":"1846","DOI":"10.1038\/jcbfm.2009.106","volume":"29","author":"DR Pillai","year":"2009","unstructured":"D.R. Pillai et al., Cerebral ischemia-reperfusion injury in rats\u2013a 3 T MRI study on biphasic blood-brain barrier opening and the dynamics of edema formation. J Cereb Blood Flow Metab 29, 1846\u20131855 (2009). https:\/\/doi.org\/10.1038\/jcbfm.2009.106","journal-title":"J Cereb Blood Flow Metab"},{"key":"423_CR66","doi-asserted-by":"publisher","first-page":"1127","DOI":"10.1161\/ATVBAHA.120.315031","volume":"41","author":"L Zhang","year":"2021","unstructured":"L. Zhang et al., Neural progenitor cell-derived extracellular vesicles enhance blood-brain barrier integrity by NF-kappaB (nuclear factor-kappaB)-dependent regulation of ABCB1 (ATP-binding cassette transporter B1) in stroke mice. Arterioscler Thromb Vasc Biol 41, 1127\u20131145 (2021). https:\/\/doi.org\/10.1161\/ATVBAHA.120.315031","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"423_CR67","doi-asserted-by":"publisher","first-page":"634347","DOI":"10.3389\/fcell.2021.634347","volume":"9","author":"MS Xu","year":"2021","unstructured":"M.S. Xu et al., Cerebral ischemia-reperfusion is associated with upregulation of cofilin-1 in the motor cortex. Front Cell Dev Biol 9, 634347 (2021). https:\/\/doi.org\/10.3389\/fcell.2021.634347","journal-title":"Front Cell Dev Biol"},{"key":"423_CR68","doi-asserted-by":"publisher","first-page":"2089","DOI":"10.2147\/DDDT.S79592","volume":"9","author":"F Zhang","year":"2015","unstructured":"F. Zhang, C.L. Xu, C.M. Liu, Drug delivery strategies to enhance the permeability of the blood-brain barrier for treatment of glioma. Drug Des Devel Ther 9, 2089\u20132100 (2015). https:\/\/doi.org\/10.2147\/DDDT.S79592","journal-title":"Drug Des Devel Ther"},{"key":"423_CR69","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1080\/10717544.2019.1616235","volume":"26","author":"D Wang","year":"2019","unstructured":"D. Wang, C. Wang, L. Wang, Y. Chen, A comprehensive review in improving delivery of small-molecule chemotherapeutic agents overcoming the blood-brain\/brain tumor barriers for glioblastoma treatment. Drug Deliv 26, 551\u2013565 (2019). https:\/\/doi.org\/10.1080\/10717544.2019.1616235","journal-title":"Drug Deliv"},{"key":"423_CR70","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics13081193","author":"DJ Lundy","year":"2021","unstructured":"D.J. Lundy, H. Nguyen, P.C.H. Hsieh, Emerging nano-carrier strategies for brain tumor drug delivery and considerations for clinical translation. Pharmaceutics (2021). https:\/\/doi.org\/10.3390\/pharmaceutics13081193","journal-title":"Pharmaceutics"},{"key":"423_CR71","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1186\/s13578-021-00650-0","volume":"11","author":"M Heidarzadeh","year":"2021","unstructured":"M. Heidarzadeh et al., Exosomal delivery of therapeutic modulators through the blood-brain barrier; promise and pitfalls. Cell Biosci 11, 142 (2021). https:\/\/doi.org\/10.1186\/s13578-021-00650-0","journal-title":"Cell Biosci"},{"key":"423_CR72","doi-asserted-by":"publisher","first-page":"4659","DOI":"10.1007\/s12035-023-03365-0","volume":"60","author":"SH Khatami","year":"2023","unstructured":"S.H. Khatami et al., Exosomes: promising delivery tools for overcoming blood-brain barrier and glioblastoma therapy. Mol Neurobiol 60, 4659\u20134678 (2023). https:\/\/doi.org\/10.1007\/s12035-023-03365-0","journal-title":"Mol Neurobiol"},{"key":"423_CR73","doi-asserted-by":"publisher","first-page":"2910","DOI":"10.7150\/thno.30879","volume":"9","author":"Y Song","year":"2019","unstructured":"Y. Song et al., M2 microglia-derived exosomes protect the mouse brain from ischemia-reperfusion injury via exosomal miR-124. Theranostics 9, 2910\u20132923 (2019). https:\/\/doi.org\/10.7150\/thno.30879","journal-title":"Theranostics"},{"key":"423_CR74","doi-asserted-by":"publisher","first-page":"1287","DOI":"10.1038\/nature08541","volume":"461","author":"M Spite","year":"2009","unstructured":"M. Spite et al., Resolvin D2 is a potent regulator of leukocytes and controls microbial sepsis. Nature 461, 1287\u20131291 (2009). https:\/\/doi.org\/10.1038\/nature08541","journal-title":"Nature"},{"key":"423_CR75","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1186\/s12951-021-00879-4","volume":"19","author":"L Guo","year":"2021","unstructured":"L. Guo et al., Surface-modified engineered exosomes attenuated cerebral ischemia\/reperfusion injury by targeting the delivery of quercetin towards impaired neurons. J Nanobiotechnol 19, 141 (2021). https:\/\/doi.org\/10.1186\/s12951-021-00879-4","journal-title":"J Nanobiotechnol"},{"key":"423_CR76","doi-asserted-by":"publisher","first-page":"6507","DOI":"10.7150\/thno.56367","volume":"11","author":"T Tian","year":"2021","unstructured":"T. Tian et al., Targeted delivery of neural progenitor cell-derived extracellular vesicles for anti-inflammation after cerebral ischemia. Theranostics 11, 6507\u20136521 (2021). https:\/\/doi.org\/10.7150\/thno.56367","journal-title":"Theranostics"},{"key":"423_CR77","doi-asserted-by":"publisher","first-page":"e2110364","DOI":"10.1002\/adma.202110364","volume":"34","author":"T Wu","year":"2022","unstructured":"T. Wu, Y. Liu, Y. Cao, Z. Liu, Engineering macrophage exosome disguised biodegradable nanoplatform for enhanced sonodynamic therapy of glioblastoma. Adv Mater 34, e2110364 (2022). https:\/\/doi.org\/10.1002\/adma.202110364","journal-title":"Adv Mater"},{"key":"423_CR78","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1186\/s12951-023-01862-x","volume":"21","author":"Y Wang","year":"2023","unstructured":"Y. Wang et al., Anti-CHAC1 exosomes for nose-to-brain delivery of miR-760\u20133p in cerebral ischemia\/reperfusion injury mice inhibiting neuron ferroptosis. J Nanobiotechnol 21, 109 (2023). https:\/\/doi.org\/10.1186\/s12951-023-01862-x","journal-title":"J Nanobiotechnol"},{"key":"423_CR79","doi-asserted-by":"publisher","first-page":"1272","DOI":"10.1021\/acsnano.8b06572","volume":"13","author":"X Dong","year":"2019","unstructured":"X. Dong, J. Gao, C.Y. Zhang, C. Hayworth, M. Frank, Z. Wang, Neutrophil membrane-derived nanovesicles alleviate inflammation to protect mouse brain injury from ischemic stroke. ACS Nano 13, 1272\u20131283 (2019). https:\/\/doi.org\/10.1021\/acsnano.8b06572","journal-title":"ACS Nano"},{"key":"423_CR80","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1186\/s12951-022-01425-6","volume":"20","author":"W Liu","year":"2022","unstructured":"W. Liu, C. Su, Y. Qi, J. Liang, L. Zhao, Y. Shi, Brain-targeted heptapeptide-loaded exosomes attenuated ischemia-reperfusion injury by promoting the transfer of healthy mitochondria from astrocytes to neurons. J Nanobiotechnol 20, 242 (2022). https:\/\/doi.org\/10.1186\/s12951-022-01425-6","journal-title":"J Nanobiotechnol"},{"key":"423_CR81","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1186\/s12951-021-00879-4","volume":"19","author":"L Guo","year":"2021","unstructured":"L. Guo et al., Surface-modified engineered exosomes attenuated cerebral ischemia\/reperfusion injury by targeting the delivery of quercetin towards impaired neurons. J Nanobiotechnol 19, 141 (2021). https:\/\/doi.org\/10.1186\/s12951-021-00879-4","journal-title":"J Nanobiotechnol"},{"key":"423_CR82","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1186\/s12951-023-01862-x","volume":"21","author":"Y Wang","year":"2023","unstructured":"Y. Wang et al., Anti-CHAC1 exosomes for nose-to-brain delivery of miR-760\u20133p in cerebral ischemia\/reperfusion injury mice inhibiting neuron ferroptosis. J Nanobiotechnol 21, 109 (2023). https:\/\/doi.org\/10.1186\/s12951-023-01862-x","journal-title":"J Nanobiotechnol"},{"key":"423_CR83","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1253\/circj.CJ-16-1124","volume":"81","author":"R Ferrari","year":"2017","unstructured":"R. Ferrari et al., Reperfusion damage\u2014a story of success, failure, and hope. Circ J 81, 131\u2013141 (2017). https:\/\/doi.org\/10.1253\/circj.CJ-16-1124","journal-title":"Circ J"},{"key":"423_CR84","doi-asserted-by":"publisher","first-page":"23975","DOI":"10.1039\/d0ra02414g","volume":"10","author":"M Sancho-Albero","year":"2020","unstructured":"M. Sancho-Albero, A. Medel-Martinez, P. Martin-Duque, Use of exosomes as vectors to carry advanced therapies. RSC Adv 10, 23975\u201323987 (2020). https:\/\/doi.org\/10.1039\/d0ra02414g","journal-title":"RSC Adv"},{"key":"423_CR85","doi-asserted-by":"publisher","first-page":"186","DOI":"10.2174\/1567201817666200122163251","volume":"17","author":"X Zhou","year":"2020","unstructured":"X. Zhou, Z. Li, W. Sun, G. Yang, C. Xing, L. Yuan, Delivery efficacy differences of intravenous and intraperitoneal injection of exosomes: perspectives from tracking dye labeled and mirna encapsulated exosomes. Curr Drug Deliv 17, 186\u2013194 (2020). https:\/\/doi.org\/10.2174\/1567201817666200122163251","journal-title":"Curr Drug Deliv"},{"key":"423_CR86","doi-asserted-by":"publisher","first-page":"e12085","DOI":"10.1002\/jev2.12085","volume":"10","author":"M Kang","year":"2021","unstructured":"M. Kang, V. Jordan, C. Blenkiron, L.W. Chamley, Biodistribution of extracellular vesicles following administration into animals: a systematic review. J Extracell Vesicles 10, e12085 (2021)","journal-title":"J Extracell Vesicles"},{"key":"423_CR87","doi-asserted-by":"publisher","first-page":"5424281","DOI":"10.1155\/2020\/5424281","volume":"2020","author":"D Guo","year":"2020","unstructured":"D. Guo et al., Roles and clinical applications of exosomes in cardiovascular disease. Biomed Res Int 2020, 5424281 (2020). https:\/\/doi.org\/10.1155\/2020\/5424281","journal-title":"Biomed Res Int"},{"key":"423_CR88","doi-asserted-by":"publisher","unstructured":"M.I. Nasser et al., Mesenchymal stem cell-derived exosome microRNA as therapy for cardiac ischemic injury. Biomed Pharmacother 143, 112118 (2021). https:\/\/doi.org\/10.1016\/j.biopha.2021","DOI":"10.1016\/j.biopha.2021"},{"key":"423_CR89","doi-asserted-by":"publisher","first-page":"152423","DOI":"10.1016\/j.prp.2019.04.015","volume":"215","author":"B Zhang","year":"2019","unstructured":"B. Zhang et al., MiR-671 ameliorates the progression of osteoarthritis in vitro and in vivo. Pathol Res Pract 215, 152423 (2019). https:\/\/doi.org\/10.1016\/j.prp.2019.04.015","journal-title":"Pathol Res Pract"},{"key":"423_CR90","doi-asserted-by":"publisher","first-page":"1815","DOI":"10.1007\/s10753-021-01460-9","volume":"44","author":"X Wang","year":"2021","unstructured":"X. Wang, Y. Zhu, C. Wu, W. Liu, Y. He, Q. Yang, Adipose-derived mesenchymal stem cells-derived exosomes carry microrna-671 to alleviate myocardial infarction through inactivating the TGFBR2\/smad2 axis. Inflammation 44, 1815\u20131830 (2021). https:\/\/doi.org\/10.1007\/s10753-021-01460-9","journal-title":"Inflammation"},{"key":"423_CR91","doi-asserted-by":"publisher","first-page":"6156","DOI":"10.18632\/aging.202611","volume":"13","author":"C Mao","year":"2021","unstructured":"C. Mao et al., Extracellular vesicles from anoxia preconditioned mesenchymal stem cells alleviate myocardial ischemia\/reperfusion injury. Aging 13, 6156\u20136170 (2021). https:\/\/doi.org\/10.18632\/aging.202611","journal-title":"Aging"},{"key":"423_CR92","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1038\/nrmicro2070","volume":"7","author":"T Bergsbaken","year":"2009","unstructured":"T. Bergsbaken, S.L. Fink, B.T. Cookson, Pyroptosis: host cell death and inflammation. Nat Rev Microbiol 7, 99\u2013109 (2009). https:\/\/doi.org\/10.1038\/nrmicro2070","journal-title":"Nat Rev Microbiol"},{"key":"423_CR93","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1038\/s41420-022-00909-6","volume":"8","author":"R Yue","year":"2022","unstructured":"R. Yue et al., Mesenchymal stem cell-derived exosomal microRNA-182\u20135p alleviates myocardial ischemia\/reperfusion injury by targeting GSDMD in mice. Cell Death Discov 8, 202 (2022). https:\/\/doi.org\/10.1038\/s41420-022-00909-6","journal-title":"Cell Death Discov"},{"key":"423_CR94","doi-asserted-by":"publisher","first-page":"7124","DOI":"10.1111\/jcmm.14562","volume":"23","author":"LR Wang","year":"2019","unstructured":"L.R. Wang et al., Role of cardiac progenitor cell-derived exosome-mediated microRNA-210 in cardiovascular disease. J Cell Mol Med 23, 7124\u20137131 (2019). https:\/\/doi.org\/10.1111\/jcmm.14562","journal-title":"J Cell Mol Med"},{"key":"423_CR95","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1111\/1755-5922.12118","volume":"33","author":"GL Gu","year":"2015","unstructured":"G.L. Gu et al., Cardioprotective effect of microRNA-21 in murine myocardial infarction. Cardiovasc Ther 33, 109\u2013117 (2015). https:\/\/doi.org\/10.1111\/1755-5922.12118","journal-title":"Cardiovasc Ther"},{"key":"423_CR96","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1016\/j.ijcard.2014.12.043","volume":"182","author":"B Yu","year":"2015","unstructured":"B. Yu et al., Exosomes secreted from GATA-4 overexpressing mesenchymal stem cells serve as a reservoir of anti-apoptotic microRNAs for cardioprotection. Int J Cardiol 182, 349\u2013360 (2015). https:\/\/doi.org\/10.1016\/j.ijcard.2014.12.043","journal-title":"Int J Cardiol"},{"key":"423_CR97","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1186\/s13287-020-01737-0","volume":"11","author":"H Cheng","year":"2020","unstructured":"H. Cheng et al., Hypoxia-challenged MSC-derived exosomes deliver miR-210 to attenuate post-infarction cardiac apoptosis. Stem Cell Res Ther 11, 224 (2020). https:\/\/doi.org\/10.1186\/s13287-020-01737-0","journal-title":"Stem Cell Res Ther"},{"key":"423_CR98","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1016\/j.scr.2009.12.003","volume":"4","author":"RC Lai","year":"2010","unstructured":"R.C. Lai et al., Exosome secreted by MSC reduces myocardial ischemia\/reperfusion injury. Stem Cell Res 4, 214\u2013222 (2010). https:\/\/doi.org\/10.1016\/j.scr.2009.12.003","journal-title":"Stem Cell Res"},{"key":"423_CR99","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1016\/j.yjmcc.2011.02.003","volume":"50","author":"S Kanki","year":"2011","unstructured":"S. Kanki, D.E. Jaalouk, S. Lee, A.Y. Yu, J. Gannon, R.T. Lee, Identification of targeting peptides for ischemic myocardium by in vivo phage display. J Mol Cell Cardiol 50, 841\u2013848 (2011). https:\/\/doi.org\/10.1016\/j.yjmcc.2011.02.003","journal-title":"J Mol Cell Cardiol"},{"key":"423_CR100","doi-asserted-by":"publisher","first-page":"1869","DOI":"10.7150\/thno.20524","volume":"8","author":"A Vandergriff","year":"2018","unstructured":"A. Vandergriff et al., Targeting regenerative exosomes to myocardial infarction using cardiac homing peptide. Theranostics 8, 1869\u20131878 (2018). https:\/\/doi.org\/10.7150\/thno.20524","journal-title":"Theranostics"},{"key":"423_CR101","doi-asserted-by":"publisher","first-page":"30081","DOI":"10.1021\/acsami.8b08449","volume":"10","author":"K Zhang","year":"2018","unstructured":"K. Zhang et al., Enhanced therapeutic effects of mesenchymal stem cell-derived exosomes with an injectable hydrogel for hindlimb ischemia treatment. ACS Appl Mater Interfac 10, 30081\u201330091 (2018)","journal-title":"ACS Appl Mater Interfac"},{"key":"423_CR102","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/j.jconrel.2014.12.013","volume":"199","author":"T Smyth","year":"2015","unstructured":"T. Smyth, M. Kullberg, N. Malik, P. Smith-Jones, M.W. Graner, T.J. Anchordoquy, Biodistribution and delivery efficiency of unmodified tumor-derived exosomes. J Control Releas 199, 145\u2013155 (2015). https:\/\/doi.org\/10.1016\/j.jconrel.2014.12.013","journal-title":"J Control Releas"},{"key":"423_CR103","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.jbiotec.2013.03.013","volume":"165","author":"Y Takahashi","year":"2013","unstructured":"Y. Takahashi et al., Visualization and in vivo tracking of the exosomes of murine melanoma B16-BL6 cells in mice after intravenous injection. J Biotechnol 165, 77\u201384 (2013). https:\/\/doi.org\/10.1016\/j.jbiotec.2013.03.013","journal-title":"J Biotechnol"},{"key":"423_CR104","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1038\/s41569-020-00499-9","volume":"18","author":"S Sahoo","year":"2021","unstructured":"S. Sahoo, T. Kariya, K. Ishikawa, Targeted delivery of therapeutic agents to the heart. Nat Rev Cardiol 18, 389\u2013399 (2021). https:\/\/doi.org\/10.1038\/s41569-020-00499-9","journal-title":"Nat Rev Cardiol"},{"key":"423_CR105","doi-asserted-by":"publisher","DOI":"10.1002\/anbr.202100047","author":"KT Wagner","year":"2021","unstructured":"K.T. Wagner, M. Radisic, A new role for extracellular vesicles in cardiac tissue engineering and regenerative medicine. Adv Nanobiomed Res (2021). https:\/\/doi.org\/10.1002\/anbr.202100047","journal-title":"Adv Nanobiomed Res"},{"key":"423_CR106","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1093\/eurheartj\/ehw240","volume":"38","author":"R Gallet","year":"2017","unstructured":"R. Gallet et al., Exosomes secreted by cardiosphere-derived cells reduce scarring, attenuate adverse remodelling, and improve function in acute and chronic porcine myocardial infarction. Eur Heart J 38, 201\u2013211 (2017). https:\/\/doi.org\/10.1093\/eurheartj\/ehw240","journal-title":"Eur Heart J"},{"key":"423_CR107","doi-asserted-by":"publisher","first-page":"e2100312","DOI":"10.1002\/adhm.202100312","volume":"11","author":"J Tang","year":"2022","unstructured":"J. Tang et al., Injection-free delivery of MSC-derived extracellular vesicles for myocardial infarction therapeutics. Adv Healthc Mater 11, e2100312 (2022). https:\/\/doi.org\/10.1002\/adhm.202100312","journal-title":"Adv Healthc Mater"},{"key":"423_CR108","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1016\/j.msec.2019.01.122","volume":"99","author":"C Han","year":"2019","unstructured":"C. Han et al., Delivery of miR-675 by stem cell-derived exosomes encapsulated in silk fibroin hydrogel prevents aging-induced vascular dysfunction in mouse hindlimb. Mater. Sci. Eng., C 99, 322\u2013332 (2019)","journal-title":"Mater. Sci. Eng., C"},{"key":"423_CR109","doi-asserted-by":"publisher","first-page":"56892","DOI":"10.1021\/acsami.1c16481","volume":"13","author":"Y Zou","year":"2021","unstructured":"Y. Zou et al., Restoring cardiac functions after myocardial infarction\u2013ischemia\/reperfusion via an exosome anchoring conductive hydrogel. ACS Appl Mater Interfac 13, 56892\u201356908 (2021)","journal-title":"ACS Appl Mater Interfac"},{"key":"423_CR110","doi-asserted-by":"publisher","first-page":"E698","DOI":"10.1532\/hsf.4919","volume":"25","author":"H Hu","year":"2022","unstructured":"H. Hu, L. Qi, C. Ren, S. Yan, M2 macrophage-derived exosomes regulate myocardial ischemia-reperfusion and pyroptosis via ROS\/NLRP3 pathway. Heart Surg Forum 25, E698\u2013E708 (2022). https:\/\/doi.org\/10.1532\/hsf.4919","journal-title":"Heart Surg Forum"},{"key":"423_CR111","doi-asserted-by":"publisher","first-page":"4455","DOI":"10.1111\/jcmm.16515","volume":"25","author":"M Katsur","year":"2021","unstructured":"M. Katsur, Z. He, V. Vinokur, R. Corteling, D.M. Yellon, S.M. Davidson, Exosomes from neuronal stem cells may protect the heart from ischaemia\/reperfusion injury via JAK1\/2 and gp130. J Cell Mol Med 25, 4455\u20134465 (2021). https:\/\/doi.org\/10.1111\/jcmm.16515","journal-title":"J Cell Mol Med"},{"key":"423_CR112","doi-asserted-by":"publisher","first-page":"H1014","DOI":"10.1152\/ajpheart.00197.2021","volume":"321","author":"GJ Schena","year":"2021","unstructured":"G.J. Schena et al., Cortical bone stem cell-derived exosomes\u2019 therapeutic effect on myocardial ischemia-reperfusion and cardiac remodeling. Am J Physiol Heart Circ Physiol 321, H1014\u2013H1029 (2021). https:\/\/doi.org\/10.1152\/ajpheart.00197.2021","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"423_CR113","doi-asserted-by":"publisher","first-page":"1249","DOI":"10.1007\/s11010-021-04343-7","volume":"477","author":"N Liu","year":"2022","unstructured":"N. Liu et al., Cardiac fibroblasts secrete exosome microRNA to suppress cardiomyocyte pyroptosis in myocardial ischemia\/reperfusion injury. Mol Cell Biochem 477, 1249\u20131260 (2022). https:\/\/doi.org\/10.1007\/s11010-021-04343-7","journal-title":"Mol Cell Biochem"},{"key":"423_CR114","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1038\/s41419-018-0274-x","volume":"9","author":"W Minghua","year":"2018","unstructured":"W. Minghua et al., Plasma exosomes induced by remote ischaemic preconditioning attenuate myocardial ischaemia\/reperfusion injury by transferring miR-24. Cell Death Dis 9, 320 (2018). https:\/\/doi.org\/10.1038\/s41419-018-0274-x","journal-title":"Cell Death Dis"},{"key":"423_CR115","doi-asserted-by":"publisher","first-page":"1541","DOI":"10.1161\/HYPERTENSIONAHA.121.17574","volume":"78","author":"H Wang","year":"2021","unstructured":"H. Wang et al., Percutaneous intracoronary delivery of plasma extracellular vesicles protects the myocardium against ischemia-reperfusion injury in canis. Hypertension 78, 1541\u20131554 (2021). https:\/\/doi.org\/10.1161\/HYPERTENSIONAHA.121.17574","journal-title":"Hypertension"},{"key":"423_CR116","doi-asserted-by":"publisher","first-page":"1525","DOI":"10.1016\/j.jacc.2015.02.026","volume":"65","author":"JM Vicencio","year":"2015","unstructured":"J.M. Vicencio et al., Plasma exosomes protect the myocardium from ischemia-reperfusion injury. J Am Coll Cardiol 65, 1525\u20131536 (2015). https:\/\/doi.org\/10.1016\/j.jacc.2015.02.026","journal-title":"J Am Coll Cardiol"},{"key":"423_CR117","doi-asserted-by":"publisher","first-page":"1323","DOI":"10.21037\/atm-21-3557","volume":"9","author":"D Shen","year":"2021","unstructured":"D. Shen, Z. He, Mesenchymal stem cell-derived exosomes regulate the polarization and inflammatory response of macrophages via miR-21\u20135p to promote repair after myocardial reperfusion injury. Ann Transl Med 9, 1323 (2021). https:\/\/doi.org\/10.21037\/atm-21-3557","journal-title":"Ann Transl Med"},{"key":"423_CR118","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/j.matbio.2014.01.010","volume":"35","author":"K Moreth","year":"2014","unstructured":"K. Moreth et al., Biglycan-triggered TLR-2- and TLR-4-signaling exacerbates the pathophysiology of ischemic acute kidney injury. Matrix Biol 35, 143\u2013151 (2014). https:\/\/doi.org\/10.1016\/j.matbio.2014.01.010","journal-title":"Matrix Biol"},{"key":"423_CR119","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1186\/s13643-022-02003-5","volume":"11","author":"XQ Li","year":"2022","unstructured":"X.Q. Li, J.F. Liu, H. Liu, Y. Meng, Extracellular vesicles for ischemia\/reperfusion injury-induced acute kidney injury: a systematic review and meta-analysis of data from animal models. Syst Rev 11, 197 (2022). https:\/\/doi.org\/10.1186\/s13643-022-02003-5","journal-title":"Syst Rev"},{"key":"423_CR120","doi-asserted-by":"publisher","first-page":"1030","DOI":"10.1002\/stem.1047","volume":"30","author":"A Eirin","year":"2012","unstructured":"A. Eirin et al., Adipose tissue-derived mesenchymal stem cells improve revascularization outcomes to restore renal function in swine atherosclerotic renal artery stenosis. Stem Cell 30, 1030\u20131041 (2012). https:\/\/doi.org\/10.1002\/stem.1047","journal-title":"Stem Cell"},{"key":"423_CR121","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1038\/s41581-022-00586-9","volume":"18","author":"C Grange","year":"2022","unstructured":"C. Grange, B. Bussolati, Extracellular vesicles in kidney disease. Nat Rev Nephrol 18, 499\u2013513 (2022)","journal-title":"Nat Rev Nephrol"},{"key":"423_CR122","doi-asserted-by":"publisher","first-page":"F1251","DOI":"10.1152\/ajprenal.00128.2014","volume":"306","author":"M Salih","year":"2014","unstructured":"M. Salih, R. Zietse, E.J. Hoorn, Urinary extracellular vesicles and the kidney: biomarkers and beyond. Am J Physiol Ren Physiol 306, F1251\u2013F1259 (2014)","journal-title":"Am J Physiol Ren Physiol"},{"key":"423_CR123","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1038\/nrneph.2017.98","volume":"13","author":"D Karpman","year":"2017","unstructured":"D. Karpman, A.-L. St\u00e5hl, I. Arvidsson, Extracellular vesicles in renal disease. Nat Rev Nephrol 13, 545\u2013562 (2017)","journal-title":"Nat Rev Nephrol"},{"key":"423_CR124","doi-asserted-by":"publisher","first-page":"5248","DOI":"10.7150\/thno.54550","volume":"11","author":"JY Cao","year":"2021","unstructured":"J.Y. Cao et al., Exosomal miR-125b-5p deriving from mesenchymal stem cells promotes tubular repair by suppression of p53 in ischemic acute kidney injury. Theranostics 11, 5248\u20135266 (2021). https:\/\/doi.org\/10.7150\/thno.54550","journal-title":"Theranostics"},{"key":"423_CR125","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2022.899869","volume":"10","author":"J Huang","year":"2022","unstructured":"J. Huang et al., Mesenchymal stem cells-derived exosomes ameliorate ischemia\/reperfusion induced acute kidney injury in a porcine model. Front Cell Dev Biol 10, 899869 (2022)","journal-title":"Front Cell Dev Biol"},{"key":"423_CR126","doi-asserted-by":"publisher","first-page":"4014","DOI":"10.1021\/acsnano.9b08207","volume":"14","author":"H Cao","year":"2020","unstructured":"H. Cao et al., In vivo tracking of mesenchymal stem cell-derived extracellular vesicles improving mitochondrial function in renal ischemia\u2013reperfusion injury. ACS Nano 14, 4014\u20134026 (2020)","journal-title":"ACS Nano"},{"key":"423_CR127","doi-asserted-by":"publisher","DOI":"10.3389\/fphys.2020.627800","volume":"11","author":"AR Shen","year":"2021","unstructured":"A.R. Shen et al., Integrin, exosome and kidney disease. Front Physiol 11, 627800 (2021)","journal-title":"Front Physiol"},{"key":"423_CR128","doi-asserted-by":"publisher","first-page":"eaaz0748","DOI":"10.1126\/sciadv.aaz0748","volume":"6","author":"TT Tang","year":"2020","unstructured":"T.T. Tang et al., Extracellular vesicle\u2013encapsulated IL-10 as novel nanotherapeutics against ischemic AKI. Sci Adv 6, eaaz0748 (2020)","journal-title":"Sci Adv"},{"key":"423_CR129","doi-asserted-by":"publisher","first-page":"e0202550","DOI":"10.1371\/journal.pone.0202550","volume":"13","author":"JM Dominguez 2nd","year":"2018","unstructured":"J.M. Dominguez 2nd., J.H. Dominguez, D. Xie, K.J. Kelly, Human extracellular microvesicles from renal tubules reverse kidney ischemia-reperfusion injury in rats. PLoS One 13, e0202550 (2018). https:\/\/doi.org\/10.1371\/journal.pone.0202550","journal-title":"PLoS One"},{"key":"423_CR130","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1016\/j.bbrc.2021.03.057","volume":"553","author":"J Du","year":"2021","unstructured":"J. Du et al., Tubular epithelial cells derived-exosomes containing CD26 protects mice against renal ischemia\/reperfusion injury by maintaining proliferation and dissipating inflammation. Biochem Biophys Res Commun 553, 134\u2013140 (2021). https:\/\/doi.org\/10.1016\/j.bbrc.2021.03.057","journal-title":"Biochem Biophys Res Commun"},{"key":"423_CR131","doi-asserted-by":"publisher","first-page":"2226","DOI":"10.1016\/j.juro.2008.07.023","volume":"180","author":"Y Zhang","year":"2008","unstructured":"Y. Zhang et al., Urine derived cells are a potential source for urological tissue reconstruction. J Urol 180, 2226\u20132233 (2008). https:\/\/doi.org\/10.1016\/j.juro.2008.07.023","journal-title":"J Urol"},{"key":"423_CR132","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1186\/s13287-016-0287-2","volume":"7","author":"ZZ Jiang","year":"2016","unstructured":"Z.Z. Jiang et al., Exosomes secreted by human urine-derived stem cells could prevent kidney complications from type I diabetes in rats. Stem Cell Res Ther 7, 24 (2016). https:\/\/doi.org\/10.1186\/s13287-016-0287-2","journal-title":"Stem Cell Res Ther"},{"key":"423_CR133","doi-asserted-by":"publisher","first-page":"9561","DOI":"10.7150\/thno.42153","volume":"10","author":"X Li","year":"2020","unstructured":"X. Li et al., Human urine-derived stem cells protect against renal ischemia\/reperfusion injury in a rat model via exosomal miR-146a-5p which targets IRAK1. Theranostics 10, 9561\u20139578 (2020). https:\/\/doi.org\/10.7150\/thno.42153","journal-title":"Theranostics"},{"key":"423_CR134","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1016\/j.kint.2021.04.039","volume":"100","author":"S Kim","year":"2021","unstructured":"S. Kim et al., Exosome-based delivery of super-repressor IkappaBalpha ameliorates kidney ischemia-reperfusion injury. Kidney Int 100, 570\u2013584 (2021). https:\/\/doi.org\/10.1016\/j.kint.2021.04.039","journal-title":"Kidney Int"},{"key":"423_CR135","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1016\/j.jconrel.2019.06.006","volume":"306","author":"JM Gudbergsson","year":"2019","unstructured":"J.M. Gudbergsson, K. Jonsson, J.B. Simonsen, K.B. Johnsen, Systematic review of targeted extracellular vesicles for drug delivery\u2014considerations on methodological and biological heterogeneity. J Control Releas 306, 108\u2013120 (2019). https:\/\/doi.org\/10.1016\/j.jconrel.2019.06.006","journal-title":"J Control Releas"},{"key":"423_CR136","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1038\/nbt.1807","volume":"29","author":"L Alvarez-Erviti","year":"2011","unstructured":"L. Alvarez-Erviti, Y. Seow, H. Yin, C. Betts, S. Lakhal, M.J. Wood, Delivery of siRNA to the mouse brain by systemic injection of targeted exosomes. Nat Biotechnol 29, 341\u2013345 (2011). https:\/\/doi.org\/10.1038\/nbt.1807","journal-title":"Nat Biotechnol"},{"key":"423_CR137","doi-asserted-by":"publisher","first-page":"21933","DOI":"10.1038\/srep21933","volume":"6","author":"YT Sato","year":"2016","unstructured":"Y.T. Sato et al., Engineering hybrid exosomes by membrane fusion with liposomes. Sci Rep 6, 21933 (2016). https:\/\/doi.org\/10.1038\/srep21933","journal-title":"Sci Rep"},{"key":"423_CR138","doi-asserted-by":"publisher","first-page":"6830","DOI":"10.1021\/acsnano.8b02053","volume":"12","author":"M Piffoux","year":"2018","unstructured":"M. Piffoux, A.K.A. Silva, C. Wilhelm, F. Gazeau, D. Tareste, Modification of extracellular vesicles by fusion with liposomes for the design of personalized biogenic drug delivery systems. ACS Nano 12, 6830\u20136842 (2018). https:\/\/doi.org\/10.1021\/acsnano.8b02053","journal-title":"ACS Nano"},{"key":"423_CR139","doi-asserted-by":"publisher","first-page":"1703","DOI":"10.1016\/j.nano.2016.03.002","volume":"12","author":"S Haque","year":"2016","unstructured":"S. Haque, M.R. Whittaker, M.P. McIntosh, C.W. Pouton, L.M. Kaminskas, Disposition and safety of inhaled biodegradable nanomedicines: opportunities and challenges. Nanomedicine 12, 1703\u20131724 (2016). https:\/\/doi.org\/10.1016\/j.nano.2016.03.002","journal-title":"Nanomedicine"},{"key":"423_CR140","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1016\/j.nano.2015.10.012","volume":"12","author":"MS Kim","year":"2016","unstructured":"M.S. Kim et al., Development of exosome-encapsulated paclitaxel to overcome MDR in cancer cells. Nanomedicine 12, 655\u2013664 (2016). https:\/\/doi.org\/10.1016\/j.nano.2015.10.012","journal-title":"Nanomedicine"},{"key":"423_CR141","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.jconrel.2014.11.029","volume":"205","author":"G Fuhrmann","year":"2015","unstructured":"G. Fuhrmann, A. Serio, M. Mazo, R. Nair, M.M. Stevens, Active loading into extracellular vesicles significantly improves the cellular uptake and photodynamic effect of porphyrins. J Control Releas 205, 35\u201344 (2015). https:\/\/doi.org\/10.1016\/j.jconrel.2014.11.029","journal-title":"J Control Releas"},{"key":"423_CR142","doi-asserted-by":"publisher","first-page":"754","DOI":"10.1038\/aps.2017.12","volume":"38","author":"X Luan","year":"2017","unstructured":"X. Luan, K. Sansanaphongpricha, I. Myers, H. Chen, H. Yuan, D. Sun, Engineering exosomes as refined biological nanoplatforms for drug delivery. Acta Pharmacol Sin 38, 754\u2013763 (2017). https:\/\/doi.org\/10.1038\/aps.2017.12","journal-title":"Acta Pharmacol Sin"},{"key":"423_CR143","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1038\/nature22341","volume":"546","author":"S Kamerkar","year":"2017","unstructured":"S. Kamerkar et al., Exosomes facilitate therapeutic targeting of oncogenic KRAS in pancreatic cancer. Nature 546, 498\u2013503 (2017). https:\/\/doi.org\/10.1038\/nature22341","journal-title":"Nature"},{"key":"423_CR144","doi-asserted-by":"publisher","first-page":"1761","DOI":"10.1021\/acs.accounts.9b00109","volume":"52","author":"OG de Jong","year":"2019","unstructured":"O.G. de Jong et al., Drug delivery with extracellular vesicles: from imagination to innovation. Acc Chem Res 52, 1761\u20131770 (2019). https:\/\/doi.org\/10.1021\/acs.accounts.9b00109","journal-title":"Acc Chem Res"},{"key":"423_CR145","doi-asserted-by":"publisher","first-page":"3183","DOI":"10.7150\/thno.52570","volume":"11","author":"Y Liang","year":"2021","unstructured":"Y. Liang, L. Duan, J. Lu, J. Xia, Engineering exosomes for targeted drug delivery. Theranostics 11, 3183\u20133195 (2021). https:\/\/doi.org\/10.7150\/thno.52570","journal-title":"Theranostics"},{"key":"423_CR146","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1186\/s12964-022-00959-4","volume":"20","author":"J Rezaie","year":"2022","unstructured":"J. Rezaie, M. Feghhi, T. Etemadi, A review on exosomes application in clinical trials: perspective, questions, and challenges. Cell Commun Signal 20, 145 (2022). https:\/\/doi.org\/10.1186\/s12964-022-00959-4","journal-title":"Cell Commun Signal"},{"key":"423_CR147","doi-asserted-by":"publisher","first-page":"1659","DOI":"10.1080\/21691401.2017.1388249","volume":"46","author":"J Zhu","year":"2018","unstructured":"J. Zhu et al., Myocardial reparative functions of exosomes from mesenchymal stem cells are enhanced by hypoxia treatment of the cells via transferring microRNA-210 in an nSMase2-dependent way. Artif Cell Nanomed Biotechnol 46, 1659\u20131670 (2018). https:\/\/doi.org\/10.1080\/21691401.2017.1388249","journal-title":"Artif Cell Nanomed Biotechnol"},{"key":"423_CR148","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1016\/j.actbio.2018.11.024","volume":"95","author":"DB Patel","year":"2019","unstructured":"D.B. Patel, C.R. Luthers, M.J. Lerman, J.P. Fisher, S.M. Jay, Enhanced extracellular vesicle production and ethanol-mediated vascularization bioactivity via a 3D-printed scaffold-perfusion bioreactor system. Acta Biomater 95, 236\u2013244 (2019). https:\/\/doi.org\/10.1016\/j.actbio.2018.11.024","journal-title":"Acta Biomater"},{"key":"423_CR149","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1007\/978-1-4939-7652-2_4","volume":"1740","author":"IK Yan","year":"2018","unstructured":"I.K. Yan, N. Shukla, D.A. Borrelli, T. Patel, Use of a hollow fiber bioreactor to collect extracellular vesicles from cells in culture. Method Mol Biol 1740, 35\u201341 (2018). https:\/\/doi.org\/10.1007\/978-1-4939-7652-2_4","journal-title":"Method Mol Biol"},{"key":"423_CR150","doi-asserted-by":"publisher","DOI":"10.1002\/adfm.202302232","author":"RC Miller","year":"2023","unstructured":"R.C. Miller, J. Lee, Y.J. Kim, H.S. Han, H. Kong, In-drop thermal cycling of microcrystal assembly for senescence control (MASC) with minimal variation in efficacy. Adv Funct Mater (2023). https:\/\/doi.org\/10.1002\/adfm.202302232","journal-title":"Adv Funct Mater"},{"key":"423_CR151","doi-asserted-by":"publisher","first-page":"e110","DOI":"10.1002\/cpcb.110","volume":"88","author":"C Coughlan","year":"2020","unstructured":"C. Coughlan et al., Exosome isolation by ultracentrifugation and precipitation and techniques for downstream analyses. Curr Protoc Cell Biol 88, e110 (2020). https:\/\/doi.org\/10.1002\/cpcb.110","journal-title":"Curr Protoc Cell Biol"},{"key":"423_CR152","doi-asserted-by":"publisher","first-page":"e0251290","DOI":"10.1371\/journal.pone.0251290","volume":"16","author":"SN Tessier","year":"2021","unstructured":"S.N. Tessier et al., Isolation of intact extracellular vesicles from cryopreserved samples. PLoS One 16, e0251290 (2021)","journal-title":"PLoS One"},{"key":"423_CR153","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics10030131","author":"F Emami","year":"2018","unstructured":"F. Emami, A. Vatanara, E.J. Park, D.H. Na, Drying technologies for the stability and bioavailability of biopharmaceuticals. Pharmaceutics (2018). https:\/\/doi.org\/10.3390\/pharmaceutics10030131","journal-title":"Pharmaceutics"},{"key":"423_CR154","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1016\/j.jconrel.2015.07.033","volume":"219","author":"CB Fox","year":"2015","unstructured":"C.B. Fox, J. Kim, L.V. Le, C.L. Nemeth, H.D. Chirra, T.A. Desai, Micro\/nanofabricated platforms for oral drug delivery. J Control Releas 219, 431\u2013444 (2015). https:\/\/doi.org\/10.1016\/j.jconrel.2015.07.033","journal-title":"J Control Releas"},{"key":"423_CR155","doi-asserted-by":"publisher","first-page":"2920","DOI":"10.3168\/jds.2014-9076","volume":"98","author":"H Izumi","year":"2015","unstructured":"H. Izumi et al., Bovine milk exosomes contain microRNA and mRNA and are taken up by human macrophages. J Dairy Sci 98, 2920\u20132933 (2015). https:\/\/doi.org\/10.3168\/jds.2014-9076","journal-title":"J Dairy Sci"},{"key":"423_CR156","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines11051487","author":"A Martinez-Santillan","year":"2023","unstructured":"A. Martinez-Santillan, J. Gonzalez-Valdez, Novel technologies for exosome and exosome-like nanovesicle procurement and enhancement. Biomedicines (2023). https:\/\/doi.org\/10.3390\/biomedicines11051487","journal-title":"Biomedicines"},{"key":"423_CR157","doi-asserted-by":"publisher","first-page":"1561","DOI":"10.1002\/mnfr.201300729","volume":"58","author":"J Mu","year":"2014","unstructured":"J. Mu et al., Interspecies communication between plant and mouse gut host cells through edible plant derived exosome-like nanoparticles. Mol Nutr Food Res 58, 1561\u20131573 (2014). https:\/\/doi.org\/10.1002\/mnfr.201300729","journal-title":"Mol Nutr Food Res"}],"container-title":["Nano Convergence"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40580-024-00423-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40580-024-00423-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40580-024-00423-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,30]],"date-time":"2024-04-30T17:15:00Z","timestamp":1714497300000},"score":1,"resource":{"primary":{"URL":"https:\/\/nanoconvergencejournal.springeropen.com\/articles\/10.1186\/s40580-024-00423-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4,30]]},"references-count":157,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["423"],"URL":"https:\/\/doi.org\/10.1186\/s40580-024-00423-8","relation":{},"ISSN":["2196-5404"],"issn-type":[{"value":"2196-5404","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,4,30]]},"assertion":[{"value":"2 December 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 April 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 April 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"18"}}